Animal Biotechnology Market Size, Trends and Insights By Product (Diagnostics Tests, Vaccines and Drugs, Reproductive and Genetic, Feed Additives, Others), By Application (Diagnosis of Animal Diseases, Treatment of Animal Diseases, Preventive Care of Animals, Drug Development, Others), By End User (Veterinary Laboratories, Point-of-Care Testing/In-house Testing, Veterinary Hospitals & Clinics, Others), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2024–2033
Report Snapshot
| Study Period: | 2024-2033 |
| Fastest Growing Market: | Asia-Pacific |
| Largest Market: | Europe |
Major Players
- Zoetis Inc.
- Merck Animal Health
- Bayer Animal Health
- Boehringer Ingelheim Animal Health
- Elanco Animal Health
- Others
Reports Description
Global Animal Biotechnology Market was valued at USD 31,474.2 Million in 2024 and is expected to reach USD 74,086.0 Million by 2033, at a CAGR of 8.94% during the forecast period 2024 – 2033.
Animal biotechnology is the use of biotechnological methods and procedures to change the genetic composition, physiology, and features of animals for a variety of objectives, including agriculture, medicine, and industry.
This discipline incorporates a broad spectrum of technologies that include genetic engineering, cloning, transgenesis, and reproductive technologies to enhance animal health, welfare, and production
Animal Biotechnology Market: Growth Factors
Rising consumption of animal-based products
The increasing use of animal-based goods is a major driver of the animal biotechnology sector. As worldwide demand for meat, dairy, and other animal-derived products rises due to population expansion, urbanization, and shifting dietary choices, there is an increasing need to improve animal agriculture efficiency and production.
Animal biotechnology helps address this need by creating technologies that increase cattle health, growth rates, reproductive effectiveness, and quality of products. Genetic engineering, breed selection, and other biotechnological procedures allow for the generation of animals with desirable characteristics such as disease resistance, increased milk or meat output, and enhanced feed conversion ratios.
Furthermore, innovations in animal biotechnology help sustainable agriculture methods, minimizing environmental impact and resource use while fulfilling the increasing global demand for animal-based food products.
For instance, according to the most recent United Nations Food and Agriculture Organization (FAO) figures, about 92 billion land animals are killed for food each year. If the demand for animal products is not lowered, it will only expand in cooperation with the rising global population.
Rapid advancements in genetic engineering
Rapid advances in genetic engineering are propelling the animal biotechnology sector by allowing precise alteration of animal genomes for desired characteristics and uses. CRISPR-Cas9 technology has transformed genetic modification, allowing researchers to change DNA sequences in animals with remarkable precision and speed.
This has aided the production of genetically engineered animals with enhanced characteristics like as disease resistance, increased productivity, and better nutritional profiles.
Furthermore, advances in reproductive technologies such as somatic cell nuclear transfer (cloning) and in vitro fertilization have broadened the range of applications in animal biotechnology, allowing for the breeding of transgenic creatures and the ongoing preservation of significant genetic resources.
These technological innovations not only accelerate research and development in agriculture, medicine, and industry, but they also stimulate investments and commercialization initiatives.
The expanding acceptance of Animal Biotechnology in research facilities, academic institutions, and clinical settings underlines the necessity for strong genomic analytic tools capable of offering complete insights into genome structure.
For instance, MaxCyte’s Inc. electroporation method offers a substitute for viral vector-based gene delivery, which is expensive to develop and has issues such as random genomic integration and immunological responses to viral components.
Animal Biotechnology Market: Restraints
Increasing concerns of transgenic animal research
Environmental and moral issues over animal suffering and genetic alteration may result in public pushback and regulatory scrutiny, impeding research and development efforts. Reservations regarding the possible environmental effects and safety hazards involved with releasing genetically modified animals into ecosystems have resulted in tougher laws and obstacles to market access.
Furthermore, negative impressions or disputes about transgenic animals may discourage funding and investment in the sector, limiting research and commercialization potential.
Furthermore, public fear about genetically modified organisms (GMOs) in the food and agricultural sectors may spread to the biotechnology business, influencing consumer approval and consumer preference for items generated from genetically altered animals.
Animal Biotechnology Market: Opportunities
Increasing demand for animal protein
The growing need for animal protein is a key driver of the animal biotechnology market. As the world’s population grows and affluence rises, so does the consumption of meat, dairy, and other animal products. Animal biotechnology helps address this need by improving the efficiency and productivity of animal production systems.
Animals with features such as quicker growth rates, greater feed conversion efficiency, and disease resistance can be created using genetic engineering, selective breeding, and other biotechnological procedures. These innovations assist farmers in meeting the increased demand for animal protein while maintaining sustainable and efficient production techniques.
Furthermore, biotechnology enables the production of healthier and more nutritious animal products that match customer demands for both safety and quality.
For instance, in accordance with the FAO, demand for animal protein, notably chicken and pig, is rising owing to population growth, urbanization, and increased purchasing power. The FAO estimates that 40% of worldwide arable land is now utilized to feed cattle, and there is a significant opportunity to improve the sustainability of agri-food systems by optimizing land usage.
Animal Biotechnology Market: Segmentation Analysis
The Global Animal Biotechnology market is segmented by product, application, end user and region. Based on product, the market is classified into diagnostics tests, vaccines, drugs, reproductive and genetic, feed additives, and others.
Diagnostics tests dominated the market in 2022 with a market share of 55% and is expected to keep its dominance during the forecast period 2024-2033. Diagnostic tests propel the animal biotechnology business by offering critical insights into animal health, allowing for disease identification, monitoring, and control.
These tests use biotechnological developments to examine biological samples, such as blood, tissue, and body fluids, for the existence of infections, genetic abnormalities, or other markers of health.
The necessity for diagnostic tests in animal biotechnology is driven by the need for rapid illness diagnosis, effective infectious disease management, and the goal to increase profitability and production in agriculture and veterinary care.
Advancements in molecular diagnostics and point-of-care testing have increased the capabilities and usability of diagnostic equipment, accelerating market growth. Moreover, diagnostic tests are critical to guaranteeing food safety, quality control, and traceability in the livestock and aquaculture industries.
Based on application, the market is classified into diagnosis of animal diseases, treatment of animal diseases, preventive care of animals, drug development, and others. The preventive care of animals segment dominated the market in 2022 with a market share of 35% and is expected to keep its dominance during the forecast period 2024-2033.
The animal biotechnology industry is substantially driven by preventive animal care, which emphasizes the need to preserve animal health and well-being through proactive approaches. This strategy makes use of biotechnological innovations and methods to create vaccinations, diagnostics, and treatments that prevent illnesses and improve general animal health.
Investments in preventative care options, such as vaccinations customized to specific diseases, can lower sickness rates, boost productivity, and improve animal product quality. The desire for preventative care promotes innovation in animal biotechnology, resulting in the creation of new vaccinations, diagnostics, and other biologics.
Furthermore, as customers prioritize animal welfare and sustainable agriculture methods, the market for preventative care solutions based on biotechnology is likely to expand.
Based on end user, the market is classified as veterinary laboratories, point-of-care testing/in-house testing, veterinary hospitals & clinics, and others. The veterinary hospitals and clinics segment dominated the market in 2022 with a market share of 55% and is expected to keep its dominance during the forecast period 2024-2033.
Veterinary hospitals and clinics play an important role in driving the animal biotechnology market by being essential players in adopting and implementing of biotechnological breakthroughs in animal health care.
Veterinary clinics offer genetic testing services to assist detect hereditary disorders and guide breeding programs to generate healthier animals. Furthermore, clinics provide innovative therapies such as gene therapy and stem cell treatment to address a variety of health issues in pets and animals.
In addition, veterinary clinics are key venues for performing clinical trials and research studies, which provide essential information and insights for the development of novel biotechnological products and therapies.
Report Scope
| Feature of the Report | Details |
| Market Size in 2024 | USD 31,474.2 Million |
| Projected Market Size in 2033 | USD 74,086.0 Million |
| Market Size in 2023 | USD 28,900.0 Million |
| CAGR Growth Rate | 8.94% CAGR |
| Base Year | 2023 |
| Forecast Period | 2024-2033 |
| Key Segment | By Product, Application, End User and Region |
| Report Coverage | Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends |
| Regional Scope | North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America |
| Buying Options | Request tailored purchasing options to fulfil your requirements for research. |
Animal Biotechnology Market: Regional Analysis
By region, Animal Biotechnology market is segmented into North America, Europe, Asia-Pacific, Latin America, the Middle East & Africa. North America dominated the global Animal Biotechnology market in 2022 with a market share of 45% in 2022 and is expected to keep its dominance during the forecast period 2024-2033.
North America dominates the animal biotechnology industry owing to its top-notch research infrastructure, strong regulatory frameworks, and substantial investment in biotechnological innovation. The region is home to major academic institutions, research organizations, and biotechnology enterprises that have pioneered advances in animal biotechnology.
Furthermore, North America’s proactive approach to biotechnology study and development encourages cooperation among academia, business, and government agencies, which speeds up the translation of scientific findings into commercial applications.
Favourable regulatory regimes and supporting policies help to drive market expansion by making it easier to approve and commercialize genetically modified animals and biotechnological goods.
Furthermore, North America’s significant focus on sustainable food production and supply motivates investments in animal biotechnology to create livestock with better features such as disease resistance, higher productivity, and enhanced nutritional value, addressing global concerns.
Animal Biotechnology Market: Recent Developments
- In September 2022, Heska Corporation, a global leader in the production of innovative veterinary diagnostic and specialized products, declared that it purchased the majority ownership of Biotech Laboratories U.S.A. LLC.
- In October 2022, Embark Veterinary, Inc. produced a DNA test for purebred dogs. The kit provides purebred owners with proprietary, actionable health information to help pinpoint diagnoses, treatment plans, and monitoring that can simply be shared with a veterinarian.
- In May 2022, Boehringer Ingelheim India introduced the VAXXITEK HVT+IBD poultry vaccine. VAXXITEK HVT+IBD, an innovative vaccine, is a one-shot vaccination that provides lifetime immunity for all types of production hens, including broilers, layers, and breeders.
List of the prominent players in the Animal Biotechnology Market:
- Zoetis Inc.
- Merck Animal Health
- Bayer Animal Health
- Boehringer Ingelheim Animal Health
- Elanco Animal Health
- Thermo Fisher Scientific Inc.
- Genus plc
- Intrexon Corporation
- Trans Ova Genetics
- Envigo
- Viagen Pets
- Genus ABS
- Hendrix Genetics
- Inguran LLC
- Avantea
- Transgenic Inc.
- Semex
- Transposagen Biopharmaceuticals
- Clonea Pty Ltd.
- BGI Group
- Others
These key players are adopting various growth strategies such as mergers & acquisitions, joint ventures, expansion, strategic alliances, new product launches, etc. to enhance their business operations and revenues.
The Animal Biotechnology Market is segmented as follows:
By Product
- Diagnostics Tests
- Vaccines and Drugs
- Reproductive and Genetic
- Feed Additives
- Others
By Application
- Diagnosis of Animal Diseases
- Treatment of Animal Diseases
- Preventive Care of Animals
- Drug Development
- Others
By End User
- Veterinary Laboratories
- Point-of-Care Testing/In-house Testing
- Veterinary Hospitals & Clinics
- Others
Regional Coverage:
North America
- U.S.
- Canada
- Mexico
- Rest of North America
Europe
- Germany
- France
- U.K.
- Russia
- Italy
- Spain
- Netherlands
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Taiwan
- Rest of Asia Pacific
The Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of the Middle East & Africa
Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
- Chapter 1. Preface
- 1.1 Report Description and Scope
- 1.2 Research scope
- 1.3 Research methodology
- 1.3.1 Market Research Type
- 1.3.2 Market Research Methodology
- Chapter 2. Executive Summary
- 2.1 Global Animal Biotechnology Market, (2024 – 2033) (USD Billion)
- 2.2 Global Animal Biotechnology Market: snapshot
- Chapter 3. Global Animal Biotechnology Market – Industry Analysis
- 3.1 Animal Biotechnology Market: Market Dynamics
- 3.2 Market Drivers
- 3.2.1 Rising consumption of animal-based products
- 3.2.2 Rapid advancements in genetic engineering
- 3.3 Market Restraints
- 3.4 Market Opportunities
- 3.5 Market Challenges
- 3.6 Porter’s Five Forces Analysis
- 3.7 Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By End User
- Chapter 4. Global Animal Biotechnology Market- Competitive Landscape
- 4.1 Company market share analysis
- 4.1.1 Global Animal Biotechnology Market: Company Market Share, 2022
- 4.2 Strategic development
- 4.2.1 Acquisitions & mergers
- 4.2.2 New Product launches
- 4.2.3 Agreements, partnerships, collaboration, and joint ventures
- 4.2.4 Research and development and Regional expansion
- 4.3 Price trend analysis
- 4.1 Company market share analysis
- Chapter 5. Global Animal Biotechnology Market – Product Analysis
- 5.1 Global Animal Biotechnology Market Overview: By Product
- 5.1.1 Global Animal Biotechnology Market Share, By Product, 2022 and – 2033
- 5.2 Diagnostics Tests
- 5.2.1 Global Animal Biotechnology Market by Diagnostics Tests, 2024 – 2033 (USD Billion)
- 5.3 Vaccines and Drugs
- 5.3.1 Global Animal Biotechnology Market by Vaccines and Drugs, 2024 – 2033 (USD Billion)
- 5.4 Reproductive and Genetic
- 5.4.1 Global Animal Biotechnology Market by Reproductive and Genetic, 2024 – 2033 (USD Billion)
- 5.5 Feed Additives
- 5.5.1 Global Animal Biotechnology Market by Feed Additives, 2024 – 2033 (USD Billion)
- 5.6 Others
- 5.6.1 Global Animal Biotechnology Market by Others, 2024 – 2033 (USD Billion)
- 5.1 Global Animal Biotechnology Market Overview: By Product
- Chapter 6. Global Animal Biotechnology Market – Application Analysis
- 6.1 Global Animal Biotechnology Market Overview: By Application
- 6.1.1 Global Animal Biotechnology Market Share, By Application, 2022 and – 2033
- 6.2 Diagnosis of Animal Diseases
- 6.2.1 Global Animal Biotechnology Market by Diagnosis of Animal Diseases, 2024 – 2033 (USD Billion)
- 6.3 Treatment of Animal Diseases
- 6.3.1 Global Animal Biotechnology Market by Treatment of Animal Diseases, 2024 – 2033 (USD Billion)
- 6.4 Preventive Care of Animals
- 6.4.1 Global Animal Biotechnology Market by Preventive Care of Animals, 2024 – 2033 (USD Billion)
- 6.5 Drug Development
- 6.5.1 Global Animal Biotechnology Market by Drug Development, 2024 – 2033 (USD Billion)
- 6.6 Others
- 6.6.1 Global Animal Biotechnology Market by Others, 2024 – 2033 (USD Billion)
- 6.1 Global Animal Biotechnology Market Overview: By Application
- Chapter 7. Global Animal Biotechnology Market – End User Analysis
- 7.1 Global Animal Biotechnology Market Overview: By End User
- 7.1.1 Global Animal Biotechnology Market Share, By End User, 2022 and – 2033
- 7.2 Veterinary Laboratories
- 7.2.1 Global Animal Biotechnology Market by Veterinary Laboratories, 2024 – 2033 (USD Billion)
- 7.3 Point-of-Care Testing/In-house Testing
- 7.3.1 Global Animal Biotechnology Market by Point-of-Care Testing/In-house Testing, 2024 – 2033 (USD Billion)
- 7.4 Veterinary Hospitals & Clinics
- 7.4.1 Global Animal Biotechnology Market by Veterinary Hospitals & Clinics, 2024 – 2033 (USD Billion)
- 7.5 Others
- 7.5.1 Global Animal Biotechnology Market by Others, 2024 – 2033 (USD Billion)
- 7.1 Global Animal Biotechnology Market Overview: By End User
- Chapter 8. Animal Biotechnology Market – Regional Analysis
- 8.1 Global Animal Biotechnology Market Regional Overview
- 8.2 Global Animal Biotechnology Market Share, by Region, 2022 & – 2033 (USD Billion)
- 8.3. North America
- 8.3.1 North America Animal Biotechnology Market, 2024 – 2033 (USD Billion)
- 8.3.1.1 North America Animal Biotechnology Market, by Country, 2024 – 2033 (USD Billion)
- 8.3.1 North America Animal Biotechnology Market, 2024 – 2033 (USD Billion)
- 8.4 North America Animal Biotechnology Market, by Product, 2024 – 2033
- 8.4.1 North America Animal Biotechnology Market, by Product, 2024 – 2033 (USD Billion)
- 8.5 North America Animal Biotechnology Market, by Application, 2024 – 2033
- 8.5.1 North America Animal Biotechnology Market, by Application, 2024 – 2033 (USD Billion)
- 8.6 North America Animal Biotechnology Market, by End User, 2024 – 2033
- 8.6.1 North America Animal Biotechnology Market, by End User, 2024 – 2033 (USD Billion)
- 8.7. Europe
- 8.7.1 Europe Animal Biotechnology Market, 2024 – 2033 (USD Billion)
- 8.7.1.1 Europe Animal Biotechnology Market, by Country, 2024 – 2033 (USD Billion)
- 8.7.1 Europe Animal Biotechnology Market, 2024 – 2033 (USD Billion)
- 8.8 Europe Animal Biotechnology Market, by Product, 2024 – 2033
- 8.8.1 Europe Animal Biotechnology Market, by Product, 2024 – 2033 (USD Billion)
- 8.9 Europe Animal Biotechnology Market, by Application, 2024 – 2033
- 8.9.1 Europe Animal Biotechnology Market, by Application, 2024 – 2033 (USD Billion)
- 8.10 Europe Animal Biotechnology Market, by End User, 2024 – 2033
- 8.10.1 Europe Animal Biotechnology Market, by End User, 2024 – 2033 (USD Billion)
- 8.11. Asia Pacific
- 8.11.1 Asia Pacific Animal Biotechnology Market, 2024 – 2033 (USD Billion)
- 8.11.1.1 Asia Pacific Animal Biotechnology Market, by Country, 2024 – 2033 (USD Billion)
- 8.11.1 Asia Pacific Animal Biotechnology Market, 2024 – 2033 (USD Billion)
- 8.12 Asia Pacific Animal Biotechnology Market, by Product, 2024 – 2033
- 8.12.1 Asia Pacific Animal Biotechnology Market, by Product, 2024 – 2033 (USD Billion)
- 8.13 Asia Pacific Animal Biotechnology Market, by Application, 2024 – 2033
- 8.13.1 Asia Pacific Animal Biotechnology Market, by Application, 2024 – 2033 (USD Billion)
- 8.14 Asia Pacific Animal Biotechnology Market, by End User, 2024 – 2033
- 8.14.1 Asia Pacific Animal Biotechnology Market, by End User, 2024 – 2033 (USD Billion)
- 8.15. Latin America
- 8.15.1 Latin America Animal Biotechnology Market, 2024 – 2033 (USD Billion)
- 8.15.1.1 Latin America Animal Biotechnology Market, by Country, 2024 – 2033 (USD Billion)
- 8.15.1 Latin America Animal Biotechnology Market, 2024 – 2033 (USD Billion)
- 8.16 Latin America Animal Biotechnology Market, by Product, 2024 – 2033
- 8.16.1 Latin America Animal Biotechnology Market, by Product, 2024 – 2033 (USD Billion)
- 8.17 Latin America Animal Biotechnology Market, by Application, 2024 – 2033
- 8.17.1 Latin America Animal Biotechnology Market, by Application, 2024 – 2033 (USD Billion)
- 8.18 Latin America Animal Biotechnology Market, by End User, 2024 – 2033
- 8.18.1 Latin America Animal Biotechnology Market, by End User, 2024 – 2033 (USD Billion)
- 8.19. The Middle-East and Africa
- 8.19.1 The Middle-East and Africa Animal Biotechnology Market, 2024 – 2033 (USD Billion)
- 8.19.1.1 The Middle-East and Africa Animal Biotechnology Market, by Country, 2024 – 2033 (USD Billion)
- 8.19.1 The Middle-East and Africa Animal Biotechnology Market, 2024 – 2033 (USD Billion)
- 8.20 The Middle-East and Africa Animal Biotechnology Market, by Product, 2024 – 2033
- 8.20.1 The Middle-East and Africa Animal Biotechnology Market, by Product, 2024 – 2033 (USD Billion)
- 8.21 The Middle-East and Africa Animal Biotechnology Market, by Application, 2024 – 2033
- 8.21.1 The Middle-East and Africa Animal Biotechnology Market, by Application, 2024 – 2033 (USD Billion)
- 8.22 The Middle-East and Africa Animal Biotechnology Market, by End User, 2024 – 2033
- 8.22.1 The Middle-East and Africa Animal Biotechnology Market, by End User, 2024 – 2033 (USD Billion)
- Chapter 9. Company Profiles
- 9.1 Zoetis Inc.
- 9.1.1 Overview
- 9.1.2 Financials
- 9.1.3 Product Portfolio
- 9.1.4 Business Strategy
- 9.1.5 Recent Developments
- 9.2 Merck Animal Health
- 9.2.1 Overview
- 9.2.2 Financials
- 9.2.3 Product Portfolio
- 9.2.4 Business Strategy
- 9.2.5 Recent Developments
- 9.3 Bayer Animal Health
- 9.3.1 Overview
- 9.3.2 Financials
- 9.3.3 Product Portfolio
- 9.3.4 Business Strategy
- 9.3.5 Recent Developments
- 9.4 Boehringer Ingelheim Animal Health
- 9.4.1 Overview
- 9.4.2 Financials
- 9.4.3 Product Portfolio
- 9.4.4 Business Strategy
- 9.4.5 Recent Developments
- 9.5 Elanco Animal Health
- 9.5.1 Overview
- 9.5.2 Financials
- 9.5.3 Product Portfolio
- 9.5.4 Business Strategy
- 9.5.5 Recent Developments
- 9.6 Thermo Fisher Scientific Inc.
- 9.6.1 Overview
- 9.6.2 Financials
- 9.6.3 Product Portfolio
- 9.6.4 Business Strategy
- 9.6.5 Recent Developments
- 9.7 Genus plc
- 9.7.1 Overview
- 9.7.2 Financials
- 9.7.3 Product Portfolio
- 9.7.4 Business Strategy
- 9.7.5 Recent Developments
- 9.8 Intrexon Corporation
- 9.8.1 Overview
- 9.8.2 Financials
- 9.8.3 Product Portfolio
- 9.8.4 Business Strategy
- 9.8.5 Recent Developments
- 9.9 Trans Ova Genetics
- 9.9.1 Overview
- 9.9.2 Financials
- 9.9.3 Product Portfolio
- 9.9.4 Business Strategy
- 9.9.5 Recent Developments
- 9.10 Envigo
- 9.10.1 Overview
- 9.10.2 Financials
- 9.10.3 Product Portfolio
- 9.10.4 Business Strategy
- 9.10.5 Recent Developments
- 9.11 Viagen Pets
- 9.11.1 Overview
- 9.11.2 Financials
- 9.11.3 Product Portfolio
- 9.11.4 Business Strategy
- 9.11.5 Recent Developments
- 9.12 Genus ABS
- 9.12.1 Overview
- 9.12.2 Financials
- 9.12.3 Product Portfolio
- 9.12.4 Business Strategy
- 9.12.5 Recent Developments
- 9.13 Hendrix Genetics
- 9.13.1 Overview
- 9.13.2 Financials
- 9.13.3 Product Portfolio
- 9.13.4 Business Strategy
- 9.13.5 Recent Developments
- 9.14 Inguran LLC
- 9.14.1 Overview
- 9.14.2 Financials
- 9.14.3 Product Portfolio
- 9.14.4 Business Strategy
- 9.14.5 Recent Developments
- 9.15 Avantea
- 9.15.1 Overview
- 9.15.2 Financials
- 9.15.3 Product Portfolio
- 9.15.4 Business Strategy
- 9.15.5 Recent Developments
- 9.16 Transgenic Inc.
- 9.16.1 Overview
- 9.16.2 Financials
- 9.16.3 Product Portfolio
- 9.16.4 Business Strategy
- 9.16.5 Recent Developments
- 9.17 Semex
- 9.17.1 Overview
- 9.17.2 Financials
- 9.17.3 Product Portfolio
- 9.17.4 Business Strategy
- 9.17.5 Recent Developments
- 9.18 Transposagen Biopharmaceuticals
- 9.18.1 Overview
- 9.18.2 Financials
- 9.18.3 Product Portfolio
- 9.18.4 Business Strategy
- 9.18.5 Recent Developments
- 9.19 Clonea Pty Ltd.
- 9.19.1 Overview
- 9.19.2 Financials
- 9.19.3 Product Portfolio
- 9.19.4 Business Strategy
- 9.19.5 Recent Developments
- 9.20 BGI Group
- 9.20.1 Overview
- 9.20.2 Financials
- 9.20.3 Product Portfolio
- 9.20.4 Business Strategy
- 9.20.5 Recent Developments
- 9.21 Others.
- 9.21.1 Overview
- 9.21.2 Financials
- 9.21.3 Product Portfolio
- 9.21.4 Business Strategy
- 9.21.5 Recent Developments
- 9.1 Zoetis Inc.
List Of Figures
Figures No 1 to 30
List Of Tables
Tables No 1 to 77
Report Methodology
In order to get the most precise estimates and forecasts possible, Custom Market Insights applies a detailed and adaptive research methodology centered on reducing deviations. For segregating and assessing quantitative aspects of the market, the company uses a combination of top-down and bottom-up approaches. Furthermore, data triangulation, which examines the market from three different aspects, is a recurring theme in all of our research reports. The following are critical components of the methodology used in all of our studies:
Preliminary Data Mining
On a broad scale, raw market information is retrieved and compiled. Data is constantly screened to make sure that only substantiated and verified sources are taken into account. Furthermore, data is mined from a plethora of reports in our archive and also a number of reputed & reliable paid databases. To gain a detailed understanding of the business, it is necessary to know the entire product life cycle and to facilitate this, we gather data from different suppliers, distributors, and buyers.
Surveys, technological conferences, and trade magazines are used to identify technical issues and trends. Technical data is also gathered from the standpoint of intellectual property, with a focus on freedom of movement and white space. The dynamics of the industry in terms of drivers, restraints, and valuation trends are also gathered. As a result, the content created contains a diverse range of original data, which is then cross-validated and verified with published sources.
Statistical Model
Simulation models are used to generate our business estimates and forecasts. For each study, a one-of-a-kind model is created. Data gathered for market dynamics, the digital landscape, development services, and valuation patterns are fed into the prototype and analyzed concurrently. These factors are compared, and their effect over the projected timeline is quantified using correlation, regression, and statistical modeling. Market forecasting is accomplished through the use of a combination of economic techniques, technical analysis, industry experience, and domain knowledge.
Short-term forecasting is typically done with econometric models, while long-term forecasting is done with technological market models. These are based on a synthesis of the technological environment, legal frameworks, economic outlook, and business regulations. Bottom-up market evaluation is favored, with crucial regional markets reviewed as distinct entities and data integration to acquire worldwide estimates. This is essential for gaining a thorough knowledge of the industry and ensuring that errors are kept to a minimum.
Some of the variables taken into account for forecasting are as follows:
• Industry drivers and constraints, as well as their current and projected impact
• The raw material case, as well as supply-versus-price trends
• Current volume and projected volume growth through 2032
We allocate weights to these variables and use weighted average analysis to determine the estimated market growth rate.
Primary Validation
This is the final step in our report’s estimating and forecasting process. Extensive primary interviews are carried out, both in-person and over the phone, to validate our findings and the assumptions that led to them.
Leading companies from across the supply chain, including suppliers, technology companies, subject matter experts, and buyers, use techniques like interviewing to ensure a comprehensive and non-biased overview of the business. These interviews are conducted all over the world, with the help of local staff and translators, to overcome language barriers.
Primary interviews not only aid with data validation, but also offer additional important insight into the industry, existing business scenario, and future projections, thereby improving the quality of our reports.
All of our estimates and forecasts are validated through extensive research work with key industry participants (KIPs), which typically include:
• Market leaders
• Suppliers of raw materials
• Suppliers of raw materials
• Buyers.
The following are the primary research objectives:
• To ensure the accuracy and acceptability of our data.
• Gaining an understanding of the current market and future projections.
Data Collection Matrix
| Perspective | Primary research | Secondary research |
| Supply-side |
|
|
| Demand-side |
|
|
Market Analysis Matrix
| Qualitative analysis | Quantitative analysis |
|
|
Prominent Player
- Zoetis Inc.
- Merck Animal Health
- Bayer Animal Health
- Boehringer Ingelheim Animal Health
- Elanco Animal Health
- Thermo Fisher Scientific Inc.
- Genus plc
- Intrexon Corporation
- Trans Ova Genetics
- Envigo
- Viagen Pets
- Genus ABS
- Hendrix Genetics
- Inguran LLC
- Avantea
- Transgenic Inc.
- Semex
- Transposagen Biopharmaceuticals
- Clonea Pty Ltd.
- BGI Group
- Others
FAQs
The restraints of the Animal Biotechnology market is increasing concerns of transgenic animal research.
The major driver for the Animal Biotechnology market is rising consumption of animal-based products and rapid advancements in genetic engineering.
The “Diagnostics Tests” category dominated the market in 2024.
The key players in the market are Zoetis Inc., Merck Animal Health, Bayer Animal Health, Boehringer Ingelheim Animal Health, Elanco Animal Health, Thermo Fisher Scientific Inc., Genus plc, Intrexon Corporation , Trans Ova Genetics, Envigo, Viagen Pets, Genus ABS, Hendrix Genetics, Inguran LLC, Avantea, Transgenic Inc., Semex, Transposagen Biopharmaceuticals, Clonea Pty Ltd., BGI Group, Others.
“North America” had the largest share in the Animal Biotechnology Market.
The global market is projected to grow at a CAGR of 8.94% during the forecast period, 2024-2033.
The Animal Biotechnology Market size was valued at USD 31,474.2 Million in 2024.